Trials / Unknown
UnknownNCT05550116
Clinical Evaluation of White Spot Lesions Treated by S-PRG and ICON
Clinical Evaluation of White Spot Lesions Treated by S-PRG Coating Material and Resin Sealants in Comparison With Resin Infiltration by Using Spectrophotometer and Laser Fluorescence. (A Randomized Controlled Trial) (WSLs)
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Al-Azhar University · Academic / Other
- Sex
- All
- Age
- 19 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
Randomized with (1:1) prospective, double-blind, controlled trial. Subjects will be randomized to receive S-PRG and the control group receives ICON.
Detailed description
Interventions: - All the procedures will be performed by the same clinician. DIAGNOdent will be used to assess the fluorescence loss of WSLs and the adjacent sound enamel. WSLs in permanent teeth will be treated according to the manufacturer's instructions with: * Group I (Control group): 20 teeth will be treated with ICON. * Group II ( EXPERIMENTAL) : 20 teeth will be treated with PRG BarrierCoat. Observation: - The treatment methods will be assessed immediately after the intervention, 3 months,6 months, and one year. The data will be collected for evaluation of the difference in color and fluorescence loss between the treatment groups, by using DIAGNOdent devices, over different time intervals. Ethical considerations: The research protocol is approved by the ethical committee, Faculty of Dental Medicine, Al-Azhar University and the enrolled patients should sign a written consent form.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Giomer | fluoride-releasing coating material containing surface reaction-type pre-reacted glass-ionomer (S-PRG) fillers |
| OTHER | Two composite resin sealants | Unfilled composite resin sealants |
Timeline
- Start date
- 2021-08-11
- Primary completion
- 2022-08-30
- Completion
- 2022-10-11
- First posted
- 2022-09-22
- Last updated
- 2022-09-26
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05550116. Inclusion in this directory is not an endorsement.